inherited element is only one of the components in its causation, it is worth speculating about the other cause, so that the appropriate experiments can be carried out. Three possibilities stand out.
Firstly, an autoimmune disease analogous to Hashimoto's disease of the thyroid (but if so, why does diabetes occur in patients on high doses of steroid?). Secondly, damage to the pancreas by infection, perhaps by a virus (as with mumps, but infection has, in fact, been very rarely reported). Thirdly, poisoning by a metal such as zinc or cadmium (analogous to Wilson's disease due to copper poisoning). I have some evidence from radioactive zinc studies that diabetics retain more of a dose of zinc than their spouses used as controls. I would like to suggest that experiments on the naturally occurring diabetes of dogs might be helpful. I expect that our veterinary colleagues could easily find cases of recently diagnosed diabetics and it would not be expensive to try the effect of a zinc-free diet and zinc-free water with chelation treatment to remove any metallic poisoning from the pancreas.
The inheritance of diabetes in dogs should certainly be investigated as it seems likely to be similar to the disease in humans. (12 December, p. 669) , particularly the conclusion that most of the patients did not find intensive care disturbing. I have also been occupied on a similar study, and would agree that most patients remember very little of their intensive care experiences, and even when they do their memory is often unreliable when compared with actual events. Dr. Hewitt states that a large percentage of her patients were postoperative cardiopulmonary bypass cases, and therefore had benefited from preoperative preparation and explanation for the intensive care interlude. Non-cardiopulmonary-bypass intensive therapy admissions do not have this benefit of preparation, and often find themselves plunged into an atmosphere of mechanized confusion when they first become aware of their surroundings; and these patients do show initial agitation, apprehension, and panic, but in my experience these patients can be satisfactorily managed by sedation, confident reassurance, repeated explanation, semihypnotic suggestion, kindness, and sympathy.
In a subjective survey of 263 consecutive patients discharged alive from a multidisciplinary intensive therapy unit1 it was found that 58% of cases accepted their intensive care experiences without any untoward effect and were quite happy to talk about it. A further 27% were unable to recollect ever having been in an intensive therapy unit. A smaller group, 10%, admitted having dreams, sometimes nightnares, recurring for varying periods of time following discharge. The remaining 5% could not be interviewed for various reasons. The 18 remissions we obtained varied from two to eight months, and the serum acid phosphatase levels fell or rose in parallel with the clinical state. Despite some of the risks of this treatment we feel that it can delay the fatal outcome and can frequently give a valuable remission in these patients with metastatic disease, which was described in Mr. J. D.
Fergusson's article (p. 540) as "probably the most difficult problem. ... Moreover, our policy is now to give this combined treatmnent not only to terminal patients but also at a very early stage, a few weeks after orchidectomy, because in a period when most neoplastic deposits have already been reduced to a m nimum, we hope that this hormonal-isotopic "cell kill" may get nearer to the actual eradication of the cancer.
For these earlier patients so far it is not possible to evaluate our results in terms of remission, non-remission, or cure and these will come only from a long period of followup. 
